Literature DB >> 28918102

Minimal Clinically Important Difference for the Rasch Neuropsychiatric Inventory Irritability and Aggression Scale for Traumatic Brain Injury.

James F Malec1, Flora M Hammond2.   

Abstract

OBJECTIVE: To determine the minimal clinically important difference (MCID) for a Rasch measure derived from the Irritability/Lability and Agitation/Aggression subscales of the Neuropsychiatric Inventory (NPI)-the Rasch NPI Irritability and Aggression Scale for Traumatic Brain Injury (NPI-TBI-IA).
DESIGN: Distribution-based statistical methods were applied to retrospective data to determine candidates for the MCID. These candidates were evaluated by anchoring the NPI-TBI-IA to Global Impression of Change (GIC) ratings by participants, significant others, and a supervising physician.
SETTING: Postacute rehabilitation outpatient clinic. PARTICIPANTS: 274 cases with observer ratings; 232 cases with self-ratings by participants with moderate-severe TBI at least 6 months postinjury.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: NPI-TBI-IA.
RESULTS: For observer ratings on the NPI-TBI-IA, anchored comparisons found an improvement of 0.5 SD was associated with at least minimal general improvement on GIC by a significant majority (69%-80%); 0.5 SD improvement on participant NPI-TBI-IA self-ratings was also associated with at least minimal improvement on the GIC by a substantial majority (77%-83%). The percentage indicating significant global improvement did not increase markedly on most ratings at higher levels of improvement on the NPI-TBI-IA.
CONCLUSIONS: A 0.5 SD improvement on the NPI-TBI-IA indicates the MCID for both observer and participant ratings on this measure.
Copyright © 2017 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggression; Behavior; Brain injuries; Rehabilitation

Mesh:

Year:  2017        PMID: 28918102     DOI: 10.1016/j.apmr.2017.06.038

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  2 in total

1.  Association between uncooperativeness and the glucose metabolism of patients with chronic behavioral disorders after severe traumatic brain injury: a cross-sectional retrospective study.

Authors:  Tomohiro Yamaki; Kosuke Suzuki; Yusuke Sudo; Tomihisa Niitsu; Masahiko Okai; Nobuo Oka; Masaru Odaki
Journal:  Biopsychosoc Med       Date:  2018-04-23

2.  Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.

Authors:  Ruby K Phyland; Adam McKay; John Olver; Mark Walterfang; Malcolm Hopwood; Amelia J Hicks; Duncan Mortimer; Jennie L Ponsford
Journal:  Trials       Date:  2020-07-20       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.